(44.210.83.132)
[ij] [ij] [ij] 
Email id
 

RESEARCH JOURNAL OF PHARMACY AND TECHNOLOGY
Year : 2020, Volume : 13, Issue : 12
First page : ( 5861) Last page : ( 5865)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2020.01021.5

Cost analysis of SGLT2 inhibitors in patients with type 2 diabetes in India

Sriram S.1*, Elizabeth Arul Amutha2, Akila L.3

1Postgraduate, Department of Pharmacology, Sree Balaji Medical College and Hospital, ChennaiTamil NaduIndia.

2Professor and HOD, Department of Pharmacology, Sree Balaji Medical College and Hospital, ChennaiTamil NaduIndia.

3Professor, Department of Pharmacology, Sree Balaji Medical College and Hospital, ChennaiTamil NaduIndia.

*Corresponding Author E-mail: srirammbbs@rediffmail.com

Online published on 15 February, 2021.

Abstract

Background: Millions of people worldwide are affected by diabetes and this disease has increased morbidity, compromised quality of life and also increased mortality. According to World Health Organization (WHO), India had 69.2 million people living with diabetes in 2015. Sodium glucose co-transporter 2 (SGLT2) inhibitors, a new class of oral anti-diabetic drugs, have garnered considerable attention in the recent past. In the recent AACE and ADA guidelines, SGLT2 inhibitors have moved up the ladder next only to Metformin and GLP-1 Receptor Agonists, in management of Diabetes mellitus. Methods: Prices of various Gliflozins (SGLT2 Inhibitors) marketed by different companies were obtained from pharmacies in the locality. The variation between highest and lowest price of the different molecules manufactured by various pharmaceutical companies and percentage variation in price for ten tablets was calculated. Results: 358.8% is the cost difference between the most expensive and least expensive gliflozin brand available in India. Conclusion: Cost of various molecules available in the market has to be known by the physician and kept in mind before prescribing the particular drug. Benefit to the patient and better drug compliance can be ensured by opting cheaper alternatives without compromising quality of the drug. Wherever needed, dose escalations or combination drugs should be initiated before opting Expensive drugs.

Top

Keywords

Anti diabetic drugs, Gliflozins, Cost analysis, Affordability, Glycemic control.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
751,759,525 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.